華檢醫療(01931.HK)南京ETHK大廈正式落成 作爲RWA技術研發總部
華檢醫療(01931.HK)公佈,位於南京的華檢醫療大廈(ETHK大廈)正式落成,標誌着集團「ETHK鏈上金融生態戰略」在實體化技術佈局方面取得重大突破。
大廈建築面積約7萬平方米,將作爲集團全球RWA技術研發與生態賦能的實體總部與核心樞紐,預計未來將匯聚超5,000名技術專家、研發工程師與生態合夥人。
大廈彙集自主高性能區塊鏈底層的研發與測試中心、跨鏈互操作協議的集成實驗室、智能合約安全與審計技術中心、數據隱私與合規科技(RegTech)研發單元等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.